•
Dec 31, 2021

iTeos Therapeutics Q4 2021 Earnings Report

Total Revenue
$241M
EPS
$4.88
Previous year: -$0.43
-1234.9%
Gross Profit
$240M
Cash and Equivalents
$849M
Previous year: $336M
+152.3%
Free Cash Flow
-$59M
Previous year: -$5.6M
+953.6%
Total Assets
$885M
Previous year: $345M
+156.8%

iTeos Therapeutics

iTeos Therapeutics